Cargando…
Combining Clinical and Candidate Gene Data into a Risk Score for Azathioprine-Associated Leukopenia in Routine Clinical Practice
Leukopenia is a serious, frequent side effect associated with azathioprine use. Currently, we use thiopurine methyltransferase (TPMT) testing to predict leukopenia in patients taking azathioprine. We hypothesized that a risk score incorporating additional clinical and genetic variables would improve...
Autores principales: | Anandi, Prathima, Dickson, Alyson L., Feng, QiPing, Wei, Wei-Qi, Dupont, William D., Plummer, Dale, Liu, Ge, Octaria, Rany, Barker, Katherine A., Kawai, Vivian K., Birdwell, Kelly, Cox, Nancy J., Hung, Adriana, Stein, C. Michael, Chung, Cecilia P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426242/ https://www.ncbi.nlm.nih.gov/pubmed/32054992 http://dx.doi.org/10.1038/s41397-020-0163-4 |
Ejemplares similares
-
Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity
por: Daniel, Laura L., et al.
Publicado: (2022) -
Association Between Genetically Predicted Expression of TPMT and Azathioprine Adverse Events
por: Davis, Alyssa, et al.
Publicado: (2023) -
Implementation of NUDT15 Genotyping to Prevent Azathioprine‐Induced Leukopenia for Patients With Autoimmune Disorders in Chinese Population
por: Wang, Chuang‐Wei, et al.
Publicado: (2022) -
NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients
por: Fei, Xiang, et al.
Publicado: (2018) -
C-reactive protein levels and prevalence of leukopenia in patients with inflammatory bowel disease treated with azathioprine and/or mesalazine: a real-life study
por: dos Santos, Rejani Cristine Faustino, et al.
Publicado: (2022)